Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

23 Mar 2018
Change (% chg)

$-0.84 (-4.06%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Thu, Mar 22 2018

BRIEF-Valeant Says Joseph Papa's 2017 Total Compensation $4.9 Mln

March 21 Valeant Pharmaceuticals International Inc:

BRIEF-Valeant Announces Launch Of Private Offering Of Senior Notes

March 12 Valeant Pharmaceuticals International Inc:

CANADA STOCKS-TSX tumbles as energy, Valeant shares weigh

Feb 28 Canada's main stock index slumped on Wednesday, pulled lower by energy shares that fell alongside the price of oil and as Valeant Pharmaceuticals tumbled after the company gave a weaker-than-expected revenue forecast. * The Toronto Stock Exchange's S&P/TSX composite index unofficially closed down 228.57 points, or 1.46 percent, at 15,442.58. (Reporting by Leah Schnurr Editing by James Dalgleish)

Valeant revenue forecast fizzles as competition heats up; shares dip

Valeant Pharmaceuticals on Wednesday gave a weaker-than-expected revenue forecast for 2018, as several of its major drugs face more competition from generics.

UPDATE 1-Valeant revenue forecast misses estimates as competition heats up

Feb 28 Valeant Pharmaceuticals' forecast for 2018 revenue fell below Wall Street estimates, as the company faces intensifying competition for some of its major products.

Valeant reports profit in 4th quarter on $1.3 billion tax benefit

Feb 28 Valeant Pharmaceuticals on Wednesday reported a profit in the fourth quarter compared to a year-earlier loss, as it booked a one-time benefit because of new U.S. tax laws.

Select another date: